FDA approves BMY’s Breyanzi (liso-cel) for B-cell lymphomas: https://www.prnewswire.com/news-releases/fda-approves-new-treatment-for-adults-with-relapsed-or-refractory-large-b-cell-lymphoma-301223275.html